🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Randomized, Phase IIIb, Two-period, Two-treatment Double-blind, Multi-cente...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-01
Trial ID
NCT02347085
Treatments Being Tested
A study to assess the pharmacokinetics and safety of two doses of PT010 and...
Status
Completed
Location
Research Site
Start Date
2017-04-17
Trial ID
NCT03075267
Treatments Being Tested
Randomized, Phase IIIb, Three-period, Three-treatment, Double-blind, Multi-...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-01
Trial ID
NCT02347072
Treatments Being Tested
This is a Phase I, Randomized, Double-Blind Within Device, Single-Dose, Fou...
Status
Completed
Location
Pearl Therapeutics Study Site
Start Date
2013-11
Trial ID
NCT01980615
A Randomized, Double-Blind, Single-Dose, Four-Period, Four-Treatment, Cross...
Status
Completed
Location
SNBL
Start Date
2014-07
Trial ID
NCT02196714
This is an open-label, multi-center study to evaluate the accuracy, reliabi...
Status
Completed
Location
Pearl Investigative Site
Start Date
2014-11
Trial ID
NCT02268396
Treatments Being Tested
A chronic dosing (24 weeks) study to assess the efficacy and safety GFF MDI...
Status
Completed
Location
Research Site
Start Date
2015-03-30
Trial ID
NCT02343458
Treatments Being Tested
The overall objective of this study is to assess the efficacy and safety of...
Status
Completed
Location
Pearl Investigative Site
Start Date
2013-05
Trial ID
NCT01854645